Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 14,394	$ 18,216
Accounts receivable, net of allowance of $17,829 in 2024 and $14,926 in 2023	204,119	205,503
Contract assets, net of allowance of $39 in 2024 and $35 in 2023	4,578	2,909
Taxes receivable	2,855	3,085
Prepaid expenses	31,606	17,771
Deferred costs	15,106	16,722
Other current assets	2,359	2,662
Total current assets	275,017	266,868
Fixed assets and capitalized software, net	37,836	38,599
Goodwill	299,626	302,400
Intangible assets, net	11,626	18,788
Deferred tax assets	131,357	128,051
Other assets	31,373	28,464
Total assets	786,835	783,170
Current liabilities
Accounts payable	19,743	10,348
Accrued liabilities	89,142	105,903
Current portion of unrecognized tax benefits	24,515	23,979
Contract liabilities	45,846	44,558
Current portion of long-term debt	52,500	70,000
Other current liabilities	7,953	8,402
Total current liabilities	239,699	263,190
Term Loan, net	239,331	230,052
ABL Facility	55,737	48,845
Pension obligations, net	70,828	69,388
Other liabilities	14,174	18,995
Total long-term liabilities	380,070	367,280
Commitments and contingencies (see Note 13)
Stockholders' equity
Common stock - $0.01 par value, 250,000,000 shares authorized; 63,306,246 shares issued and 35,826,908 shares outstanding at March 31, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at December 31, 2023	633	627
Additional paid-in capital	1,159,754	1,151,259
Treasury stock - 27,479,338 shares at March 31, 2024 and 27,358,037 shares at December 31, 2023	(488,087)	(485,793)
Accumulated other comprehensive loss	(15,456)	(15,191)
Accumulated deficit	(489,778)	(498,202)
Total stockholders' equity	167,066	152,700
Total liabilities and stockholders' equity	$ 786,835	$ 783,170